Physician profile
Jay Smith
NPI 1134248362
$101,909.77
in general payments reported to CMS, 2019-2025
10 companies · $35K in 2025
The $35K reported for 2025 was more than what 98% of Prosthodontics providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,149 · 2020: $128 · 2021: $1,125 · 2022: $1,585 · 2023: $31K · 2024: $31K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $88K · Travel and Lodging: $4,870 · Food and Beverage: $4,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $87,610.75 |
| Travel and Lodging | $4,869.83 |
| Food and Beverage | $4,442.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $98,312.94 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $2,296.85 | 2019-2021 | |
| Straumann USA LLC | $771.57 | 2019-2022 | |
| Thommen Medical USA, LLC | $200.50 | 2021 | |
| Biohorizons Implant Systems INC. | $121.66 | 2019 | |
| Align Technology, INC. | $86.21 | 2024 | Invisalign |
| Southern Implants North America INC | $73.60 | 2019 | |
| 3m Company | $26.04 | 2019-2020 | |
| Nobel Biocare USA | $14.20 | 2021 | |
| Voco America INC. | $6.20 | 2025 | Bifix Qm, Futurabond U, Voco Retraction Paste |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.